# Amgen

Biotech pioneer founded 1980 — Enbrel, Prolia, and PCSK9 inhibitor Repatha; large-scale CHO cell culture manufacturing at Thousand Oaks and Puerto Rico sites.

Source: https://en.bioecon.ru/companies/amgen/
Updated: 2026-06-19

- Country: United States
- Revenue: $33.4B
- Employees: ~24,000 emp

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Headquarters | Thousand Oaks, California | https://www.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.pdf, https://wwwext.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.ashx, https://wwwext.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.pdf |
| Headcount | approximately 31,500 worldwide | https://www.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.pdf, https://wwwext.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.ashx, https://wwwext.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.pdf |
| Revenue | $36.8 billion (2025) | https://www.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.pdf, https://wwwext.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.ashx, https://wwwext.amgen.com/-/media/Themes/CorporateAffairs/amgen-com/amgen-com/downloads/fact-sheets/fact_sheet_amgen.pdf |
| Production site | United States (including Puerto Rico, Rhode Island, Ohio, California), Ireland, Netherlands, and Singapore | https://investors.amgen.com/static-files/43d5c346-88b9-44b3-9201-79514b22087a |
| Capacity | Expanding and optimizing network with state-of-the-art facilities; Juncos (Puerto Rico) is one of the world's largest; Ohio and North Carolina facilities added recently | https://investors.amgen.com/news-releases/news-release-details/amgen-announces-fda-licensure-two-new-manufacturing-facilities, https://www.amgen.com/newsroom/press-releases/2026/05/amgen-announces-additional-300-million-us-manufacturing-investment-totaling-nearly-2-billion-over-the-last-year |
| Regulatory approval | Products including Enbrel, Prolia, and Repatha have received FDA and international regulatory approvals | https://investors.amgen.com/static-files/43d5c346-88b9-44b3-9201-79514b22087a, https://www.amgen.com/about/amgen-history, https://www.fiercepharma.com/pharma/amgen-s-repatha%C2%AE-evolocumab-approved-as-first-pcsk9-inhibitor-japan-for-treatment-of-high |

Independent sources: fiercepharma.com

## Technologies

- [Biologics](https://en.bioecon.ru/technology/biologics/)